The role of endothelial dysfunction in aortic aneurysms

Current Pharmaceutical Design

Volumn 21, Issue 28, 2015, Pages 4016-4034

  Siasos, Gerasimos ^a   Mourouzis, Konstantinos ^a   Oikonomou, Evangelos ^a   Tsalamandris, Sotirios ^a   Tsigkou, Vasiliki ^a   Vlasis, Konstantinos ^a   Vavuranakis, Manolis ^a   Zografos, Thodoris ^a   Dimitropoulos, Stathis ^a   Papaioannou, Theodore G ^a   Kalampogias, Aimilios ^a   Stefanadis, Christodoulos ^a   Papavassiliou, Athanasios G ^a   Tousoulis, Dimitris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Aortic aneurysms; Atherosclerosis; Cardiovascular diseases; Endothelial dysfunction; Endothelium vascular; Inflammation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COLLAGEN; COLLAGENASE; ELASTIN; ENDOTHELIN 1; INDUCIBLE NITRIC OXIDE SYNTHASE; METALLOPROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELECTIN; SUPEROXIDE;

ABDOMINAL AORTA ANEURYSM; ADVENTITIA; AORTA WALL; APOPTOSIS; ARTERIAL STIFFNESS; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; AUGMENTATION INDEX; BIOAVAILABILITY; BLOOD CLOTTING; CAROTID ARTERY; CELL TRANSFORMATION; COLLAGEN SYNTHESIS; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXERCISE; FEMORAL ARTERY; FIBRINOLYSIS; HUMAN; HYPERTENSION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LYMPHOCYTE; LYSIS; MONOCYTE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SMOKING; THROMBOCYTE ACTIVATION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; WALL STRESS; ABDOMINAL AORTA; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; INFLAMMATION; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; MONOCYTES; NITRIC OXIDE; OXIDATIVE STRESS; RISK FACTORS;

EID: 84947813592     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150826094156     Document Type: Article

References (246)

1. McGregor JC, Pollock JG, Anton HC. The value of ultrasonography in the diagnosis of abdominal aortic aneurysm. Scott Med J 1975; 20: 133-7.
2. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2015 update: a report from the american heart association. Circulation 2015; 131: e29-e322.
3. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/ Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)--summary of recommendations. J Vasc Interv Radiol 2006; 17: 1383-97; quiz 98.
4. Collaborators USBoD. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA 2013; 310: 591-608.
5. Johansson G, Swedenborg J. Ruptured abdominal aortic aneurysms: a study of incidence and mortality. Br J Surg 1986; 73: 101- 3.
6. Kuivaniemi H, Ryer EJ, Elmore JR, Hinterseher I, Smelser DT, Tromp G. Update on abdominal aortic aneurysm research: from clinical to genetic studies. Scientifica (Cairo) 2014; 2014: 564734.
7. Smelser DT, Tromp G, Elmore JR, et al. Population risk factor estimates for abdominal aortic aneurysm from electronic medical records: a case control study. BMC Cardiovasc Disord 2014; 14: 174.
8. Dobrin PB, Mrkvicka R. Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 1994; 2: 484-8.
9. Borges LF, Gomez D, Quintana M, et al. Fibrinolytic activity is associated with presence of cystic medial degeneration in aneurysms of the ascending aorta. Histopathology 2010; 57: 917-32.
10. Mao D, Lee JK, VanVickle SJ, Thompson RW. Expression of collagenase-3 (MMP-13) in human abdominal aortic aneurysms and vascular smooth muscle cells in culture. Biochem Biophys Res Commun 1999; 261: 904-10.
11. Reilly JM, Sicard GA, Lucore CL. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease. J Vasc Surg 1994; 19: 865-72.
12. Siasos G, Tousoulis D, Kioufis S, et al. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr Top Med Chem 2012; 12: 1132-48.
13. Mi T, Nie B, Zhang C, Zhou H. The elevated expression of osteopontin and NF-kappaB in human aortic aneurysms and its implication. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 602-7.
14. Vorp DA, Lee PC, Wang DH, et al. Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 2001; 34: 291-9.
15. Curci JA, Thompson RW. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? J Clin Invest 2004; 114: 168-71.
16. Martinez-Pinna R, Lindholt JS, Blanco-Colio LM, et al. Increased levels of thioredoxin in patients with abdominal aortic aneurysms (AAAs). A potential link of oxidative stress with AAA evolution. Atherosclerosis 2010; 212: 333-8.
17. Kaschina E, Scholz H, Steckelings UM, et al. Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 2009; 205: 396-403.
18. Astrand H, Ryden-Ahlgren A, Sundkvist G, Sandgren T, Lanne T. Reduced aortic wall stress in diabetes mellitus. Eur J Vasc Endovasc Surg 2007; 33: 592-8.
19. Palazzuoli A, Gallotta M, Guerrieri G, et al. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008; 4: 877-83.
20. Johnsen SH, Forsdahl SH, Singh K, Jacobsen BK. Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromso study. Arterioscler Thromb Vasc Biol 2010; 30: 1263-8.
21. Siasos G, Tousoulis D, Tsigkou V, et al. Flavonoids in atherosclerosis: an overview of their mechanisms of action. Curr Med Chem 2013; 20: 2641-60.
22. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006; 291: H985-1002.
23. Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012; 10: 4-18.
24. Tousoulis D, Charakida M, Stefanadis C. Endothelial function and inflammation in coronary artery disease. Postgrad Med J 2008; 84: 368-71.
25. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest 2005; 115: 509-17.
26. Antoniades C, Tousoulis D, Tountas C, et al. Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin C. Diabet Med 2004; 21: 552-8.
27. Tentolouris C, Tousoulis D, Antoniades C, et al. Endothelial function and proinflammatory cytokines in patients with ischemic heart disease and dilated cardiomyopathy. Int J Cardiol 2004; 94: 301-5.
28. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996; 98: 2572-9.
29. Troxler M, Naseem KM, Homer-Vanniasinkam S. Increased nitrotyrosine production in patients undergoing abdominal aortic aneurysm repair. Br J Surg 2004; 91: 1146-51.
30. Pritchard KA, Jr., Groszek L, Smalley DM, et al. Native lowdensity lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995; 77: 510-8.
31. Shinyashiki M, Pan CJ, Lopez BE, Fukuto JM. Inhibition of the yeast metal reductase heme protein fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. Free Radic Biol Med 2004; 37: 713-23.
32. Kibbe M, Billiar T, Tzeng E. Inducible nitric oxide synthase and vascular injury. Cardiovasc Res 1999; 43: 650-7.
33. Shiraya S, Miwa K, Aoki M, et al. Hypertension accelerated experimental abdominal aortic aneurysm through upregulation of nuclear factor kappaB and Ets. Hypertension 2006; 48: 628-36.
34. Saito T, Hasegawa Y, Ishigaki Y, et al. Importance of endothelial NF-kappaB signalling in vascular remodelling and aortic aneurysm formation. Cardiovasc Res 2013; 97: 106-14.
35. Kalyanasundaram A, Elmore JR, Manazer JR, et al. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 2006; 43: 117-24.
36. Wemmelund H, Hogh A, Hundborg HH, Thomsen RW, Johnsen SP, Lindholt JS. Statin use and rupture of abdominal aortic aneurysm. Br J Surg 2014; 101: 966-75.
37. Bhak RH, Wininger M, Johnson GR, et al. Factors Associated With Small Abdominal Aortic Aneurysm Expansion Rate. JAMA Surg 2014.
38. Gokani VJ, Sidloff D, Bath MF, Bown MJ, Sayers RD, Choke E. A retrospective study: Factors associated with the risk of abdominal aortic aneurysm rupture. Vascul Pharmacol 2014.
39. Golledge J, Hankey GJ, Yeap BB, Almeida OP, Flicker L, Norman PE. Reported high salt intake is associated with increased prevalence of abdominal aortic aneurysm and larger aortic diameter in older men. PLoS One 2014; 9: e102578.
40. Cassis LA, Gupte M, Thayer S, et al. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 2009; 296: H1660-5.
41. Nussberger J, Aubert JF, Bouzourene K, Pellegrin M, Hayoz D, Mazzolai L. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine. Hypertension 2008; 51: 1306-11.
42. Seto SW, Krishna SM, Moran CS, Liu D, Golledge J. Aliskiren limits abdominal aortic aneurysm, ventricular hypertrophy and atherosclerosis in an apolipoprotein-E-deficient mouse model. Clin Sci (Lond) 2014; 127: 123-34.
43. Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2004; 24: 429-34.
44. Silverberg D, Younis A, Savion N, et al. Long-term reninangiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms. J Am Soc Hypertens 2014; 8: 571-7.
45. Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensinconverting enzyme inhibitors and aortic rupture: a populationbased case-control study. Lancet 2006; 368: 659-65.
46. Sweeting MJ, Thompson SG, Brown LC, Greenhalgh RM, Powell JT. Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg 2010; 52: 1-4.
47. Railton CJ, Wolpin J, Lam-McCulloch J, Belo SE. Reninangiotensin blockade is associated with increased mortality after vascular surgery. Can J Anaesth 2010; 57: 736-44.
48. Takai S, Jin D, Miyazaki M. New approaches to blockade of the renin-angiotensin-aldosterone system: chymase as an important target to prevent organ damage. J Pharmacol Sci 2010; 113: 301-9.
49. Zhang X, Liu J, Pang X, Zhao J, Wang S, Wu D. Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NFkappaB signal pathway in rat vascular smooth muscle cells. Mol Cell Endocrinol 2014; 395: 61-8.
50. Cassis LA, Helton MJ, Howatt DA, King VL, Daugherty A. Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Br J Pharmacol 2005; 144: 443-8.
51. Zhao Y, Flavahan S, Leung SW, Xu A, Vanhoutte PM, Flavahan NA. Elevated Pressure Causes Endothelial Dysfunction in Mouse Carotid Arteries by Increasing Local Angiotensin Signaling. Am J Physiol Heart Circ Physiol 2014: ajpheart 00775 2014.
52. Wang HD, Xu S, Johns DG, et al. Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 2001; 88: 947-53.
53. Gao L, Siu KL, Chalupsky K, et al. Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 2012; 59: 158-66.
54. Shatanawi A, Lemtalsi T, Yao L, Patel C, Caldwell RB, Caldwell RW. Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway. Eur J Pharmacol 2015; 746: 106-14.
55. Fan LM, Douglas G, Bendall JK, et al. Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation 2014; 129: 2661-72.
56. Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, Cassis LA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clin Sci (Lond) 2010; 118: 681-9.
57. Poduri A, Owens AP, 3rd, Howatt DA, et al. Regional variation in aortic AT1b receptor mRNA abundance is associated with contractility but unrelated to atherosclerosis and aortic aneurysms. PLoS One 2012; 7: e48462.
58. Cassis LA, Rateri DL, Lu H, Daugherty A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arterioscler Thromb Vasc Biol 2007; 27: 380-6.
59. Rateri DL, Moorleghen JJ, Knight V, et al. Depletion of endothelial or smooth muscle cell-specific angiotensin II type 1a receptors does not influence aortic aneurysms or atherosclerosis in LDL receptor deficient mice. PLoS One 2012; 7: e51483.
60. Siasos G, Tsigkou V, Kokkou E, et al. Smoking and atherosclerosis: mechanisms of disease and new therapeutic approaches. Curr Med Chem 2014; 21: 3936-48.
61. Steffen Y, Vuillaume G, Stolle K, et al. Cigarette smoke and LDL cooperate in reducing nitric oxide bioavailability in endothelial cells via effects on both eNOS and NADPH oxidase. Nitric Oxide 2012; 27: 176-84.
62. Yang PT, Yuan H, Wang YQ, Cao X, Wu LX, Chen ZH. Correlations between brachial endothelial function and cardiovascular risk factors: a survey of 2,511 Chinese subjects. J Thorac Dis 2014; 6: 1441-51.
63. Skaug EA, Madssen E, Aspenes ST, Wisloff U, Ellingsen O. Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study. PLoS One 2014; 9: e101371.
64. McEvoy JW, Blaha MJ, DeFilippis AP, et al. Cigarette Smoking and Cardiovascular Events: Role of Inflammation and Subclinical Atherosclerosis: The Multiethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 2015.
65. Li ZZ, Dai QY. Pathogenesis of abdominal aortic aneurysms: role of nicotine and nicotinic acetylcholine receptors. Mediators Inflamm 2012; 2012: 103120.
66. Kangavari S, Matetzky S, Shah PK, et al. Smoking increases inflammation and metalloproteinase expression in human carotid atherosclerotic plaques. J Cardiovasc Pharmacol Ther 2004; 9: 291- 8.
67. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2005; 102: 9056-61.
68. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes 2007; 56: 118-26.
69. Cosentino F, Barker JE, Brand MP, et al. Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterindeficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 496-502.
70. Crabtree MJ, Hale AB, Channon KM. Dihydrofolate reductase protects endothelial nitric oxide synthase from uncoupling in tetrahydrobiopterin deficiency. Free Radic Biol Med 2011; 50: 1639-46.
71. Siu KL, Miao XN, Cai H. Recoupling of eNOS with folic acid prevents abdominal aortic aneurysm formation in angiotensin IIinfused apolipoprotein E null mice. PLoS One 2014; 9: e88899.
72. Siu KL, Cai H. Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm. Am J Physiol Heart Circ Physiol 2014; 307: H1559-64.
73. Kuhlencordt PJ, Gyurko R, Han F, et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001; 104: 448-54.
74. Seto SW, Krishna SM, Yu H, Liu D, Khosla S, Golledge J. Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE-/-) knockout mice. PLoS One 2013; 8: e58481.
75. Takayanagi T, Crawford KJ, Kobayashi T, et al. Caveolin 1 is critical for abdominal aortic aneurysm formation induced by angiotensin II and inhibition of lysyl oxidase. Clin Sci (Lond) 2014; 126: 785-94.
76. Metaxa E, Meng H, Kaluvala SR, Szymanski MP, Paluch RA, Kolega J. Nitric oxide-dependent stimulation of endothelial cell proliferation by sustained high flow. Am J Physiol Heart Circ Physiol 2008; 295: H736-42.
77. Kotani K, Shimomura T, Murakami F, et al. Allele frequency of human endothelial nitric oxide synthase gene polymorphism in abdominal aortic aneurysm. Intern Med 2000; 39: 537-9.
78. Liao MF, Jing ZP, Bao JM, et al. Role of nitric oxide and inducible nitric oxide synthase in human abdominal aortic aneurysms: a preliminary study. Chin Med J (Engl) 2006; 119: 312-8.
79. Zhang J, Schmidt J, Ryschich E, Mueller-Schilling M, Schumacher H, Allenberg JR. Inducible nitric oxide synthase is present in human abdominal aortic aneurysm and promotes oxidative vascular injury. J Vasc Surg 2003; 38: 360-7.
80. Armstrong PJ, Franklin DP, Carey DJ, Elmore JR. Suppression of experimental aortic aneurysms: comparison of inducible nitric oxide synthase and cyclooxygenase inhibitors. Ann Vasc Surg 2005; 19: 248-57.
81. Shang T, Liu Z, Zhou M, Liu CJ. [Tanshinone IIA attenuates the development of elastase-induced abdominal aortic aneurysm of rat]. Zhonghua Wai Ke Za Zhi 2012; 50: 923-7.
82. Lizarbe TR, Tarin C, Gomez M, et al. Nitric oxide induces the progression of abdominal aortic aneurysms through the matrix metalloproteinase inducer EMMPRIN. Am J Pathol 2009; 175: 1421- 30.
83. Lizarbe TR, Garcia-Rama C, Tarin C, et al. Nitric oxide elicits functional MMP-13 protein-tyrosine nitration during wound repair. FASEB J 2008; 22: 3207-15.
84. Norgauer J, Hildenbrand T, Idzko M, et al. Elevated expression of extracellular matrix metalloproteinase inducer (CD147) and membrane- type matrix metalloproteinases in venous leg ulcers. Br J Dermatol 2002; 147: 1180-6.
85. Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520-8.
86. Guzik B, Sagan A, Ludew D, et al. Mechanisms of oxidative stress in human aortic aneurysms--association with clinical risk factors for atherosclerosis and disease severity. Int J Cardiol 2013; 168: 2389-96.
87. Paik DC, Ramey WG, Dillon J, Tilson MD. The nitrite/elastin reaction: implications for in vivo degenerative effects. Connect Tissue Res 1997; 36: 241-51.
88. Curtis BM, Leix KA, Ji Y, Glaves RS, Ash DE, Mohanty DK. Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death. Biochem Biophys Res Commun 2014; 450: 208-12.
89. Channon KM, Qian H, George SE. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arterioscler Thromb Vasc Biol 2000; 20: 1873-81.
90. Hwang JS, Kim HJ, Kim G, et al. PPARdelta reduces abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice by regulating extracellular matrix homeostasis and inflammatory responses. Int J Cardiol 2014; 174: 43-50.
91. Anderson EM, Kwee BJ, Lewin SA, Raimondo T, Mehta M, Mooney D. Local delivery of VEGF and SDF enhances endothelial progenitor cell recruitment and resultant recovery from ischemia. Tissue Eng Part A 2014.
92. Dawson J, Tooze J, Cockerill G, Choke E, Loftus I, Thompson MM. Endothelial progenitor cells and abdominal aortic aneurysms. Ann N Y Acad Sci 2006; 1085: 327-30.
93. Parietti E, Pallandre JR, Deschaseaux F, et al. Presence of circulating endothelial progenitor cells and levels of stromal-derived factor- 1alpha are associated with ascending aorta aneurysm size. Eur J Cardiothorac Surg 2011; 40: e6-12.
94. Sung SH, Wu TC, Chen JS, et al. Reduced number and impaired function of circulating endothelial progenitor cells in patients with abdominal aortic aneurysm. Int J Cardiol 2013; 168: 1070-7.
95. Fang X, Zhao R, Wang K, et al. Bone marrow-derived endothelial progenitor cells are involved in aneurysm repair in rabbits. J Clin Neurosci 2012; 19: 1283-6.
96. Siasos G, Zografos T, Oikonomou E, Papavassiliou AG, Stefanadis C, Tousoulis D. Flow-mediated dilation: Is it just a research tool or a useful biomarker for cardiovascular prognosis. Int J Cardiol 2015; 180: 154-7.
97. Tousoulis D, Simopoulou C, Papageorgiou N, et al. Endothelial dysfunction in conduit arteries and in microcirculation. Novel therapeutic approaches. Pharmacol Ther 2014; 144: 253-67.
98. Tousoulis D, Koutsogiannis M, Papageorgiou N, et al. Endothelial dysfunction: potential clinical implications. Minerva Med 2010; 101: 271-84.
99. Knipp BS, Peterson DA, Rajagopalan S, et al. Impaired vasoreactivity despite an increase in plasma nitrite in patients with abdominal aortic aneurysms. J Vasc Surg 2002; 35: 363-7.
100. Waeckel L, Badier-Commander C, Damery T, et al. Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. Pflugers Arch 2014.
101. Medina F, de Haro J, Florez A, Acin F. Relationship between endothelial dependent vasodilation and size of abdominal aortic aneurysms. Ann Vasc Surg 2010; 24: 752-7.
102. Tousoulis D, Papageorgiou N, Latsios G, Siasos G, Antoniades C, Stefanadis C. C-reactive protein and endothelial dysfunction: gazing at the coronaries. Int J Cardiol 2011; 152: 1-3.
103. De Haro J, Acin F, Bleda S, Varela C, Medina FJ, Esparza L. Prediction of asymptomatic abdominal aortic aneurysm expansion by means of rate of variation of C-reactive protein plasma levels. J Vasc Surg 2012; 56: 45-52.
104. Cetin M, Kocaman SA, Durakoglugil ME, et al. Independent determinants of ascending aortic dilatation in hypertensive patients: smoking, endothelial dysfunction, and increased epicardial adipose tissue. Blood Press Monit 2012; 17: 223-30.
105. Siasos G, Tousoulis D, Kollia C, et al. Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches. Curr Med Chem 2012; 19: 1193-209.
106. Yoshida S, Fuster JJ, Walsh K. Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis 2014; 235: 339-46.
107. Akamatsu D, Sato A, Goto H, et al. Nitroglycerin-mediated vasodilatation of the brachial artery may predict long-term cardiovascular events irrespective of the presence of atherosclerotic disease. J Atheroscler Thromb 2010; 17: 1266-74.
108. Lam CF, Peterson TE, Richardson DM, et al. Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 2006; 290: H786-93.
109. Harrison DG, Widder J, Grumbach I, Chen W, Weber M, Searles C. Endothelial mechanotransduction, nitric oxide and vascular inflammation. J Intern Med 2006; 259: 351-63.
110. dela Paz NG, Melchior B, Frangos JA. Early VEGFR2 activation in response to flow is VEGF-dependent and mediated by MMP activity. Biochem Biophys Res Commun 2013; 434: 641-6.
111. Ding Z, Liu S, Wang X, et al. Hemodynamic Shear Stress Via ROS Modulates PCSK9 Expression in Human Vascular Endothelial and Smooth Muscle Cells and Along the Mouse Aorta. Antioxid Redox Signal 2014.
112. Cecchi E, Giglioli C, Valente S, et al. Role of hemodynamic shear stress in cardiovascular disease. Atherosclerosis 2011; 214: 249-56.
113. Orr AW, Sanders JM, Bevard M, Coleman E, Sarembock IJ, Schwartz MA. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J Cell Biol 2005; 169: 191-202.
114. Shav D, Gotlieb R, Zaretsky U, Elad D, Einav S. Wall shear stress effects on endothelial-endothelial and endothelial-smooth muscle cell interactions in tissue engineered models of the vascular wall. PLoS One 2014; 9: e88304.
115. Speelman L, Hellenthal FA, Pulinx B, et al. The influence of wall stress on AAA growth and biomarkers. Eur J Vasc Endovasc Surg 2010; 39: 410-6.
116. Raghavan ML, Vorp DA, Federle MP, Makaroun MS, Webster MW. Wall stress distribution on three-dimensionally reconstructed models of human abdominal aortic aneurysm. J Vasc Surg 2000; 31: 760-9.
117. Boyd AJ, Kuhn DC, Lozowy RJ, Kulbisky GP. Low wall shear stress predominates at sites of abdominal aortic aneurysm rupture. J Vasc Surg 2015.
118. Macek Jilkova Z, Deplano V, Verdier C, Toungara M, Geindreau C, Duperray A. Wall shear stress and endothelial cells dysfunction in the context of abdominal aortic aneurysms. Comput Methods Biomech Biomed Engin 2013; 16 Suppl 1: 27-9.
119. Liu X, Wang Z, Zhao P, et al. Nitric oxide transport in normal human thoracic aorta: effects of hemodynamics and nitric oxide scavengers. PLoS One 2014; 9: e112395.
120. Dolan JM, Kolega J, Meng H. High wall shear stress and spatial gradients in vascular pathology: a review. Ann Biomed Eng 2013; 41: 1411-27.
121. Humphrey JD, Holzapfel GA. Mechanics, mechanobiology, and modeling of human abdominal aorta and aneurysms. J Biomech 2012; 45: 805-14.
122. Siasos G, Tousoulis D, Antoniades C, Stefanadi E, Stefanadis C. LArginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis? Int J Cardiol 2007; 116: 300-8.
123. Tousoulis D, Boger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Mechanisms of disease: L-arginine in coronary atherosclerosis-- a clinical perspective. Nat Clin Pract Cardiovasc Med 2007; 4: 274-83.
124. Gavazzi G, Deffert C, Trocme C, Schappi M, Herrmann FR, Krause KH. NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension 2007; 50: 189-96.
125. Kigawa Y, Miyazaki T, Lei XF, et al. NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol 2014; 34: 2413-20.
126. Satoh K, Nigro P, Berk BC. Oxidative stress and vascular smooth muscle cell growth: a mechanistic linkage by cyclophilin A. Antioxid Redox Signal 2010; 12: 675-82.
127. Xiong W, Mactaggart J, Knispel R, et al. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis 2009; 202: 128-34.
128. Pincemail J, Defraigne JO, Cheramy-Bien JP, et al. On the potential increase of the oxidative stress status in patients with abdominal aortic aneurysm. Redox Rep 2012; 17: 139-44.
129. Sinha I, Pearce CG, Cho BS, et al. Differential regulation of the superoxide dismutase family in experimental aortic aneurysms and rat aortic explants. J Surg Res 2007; 138: 156-62.
130. Ramos-Mozo P, Madrigal-Matute J, Martinez-Pinna R, et al. Proteomic analysis of polymorphonuclear neutrophils identifies catalase as a novel biomarker of abdominal aortic aneurysm: potential implication of oxidative stress in abdominal aortic aneurysm progression. Arterioscler Thromb Vasc Biol 2011; 31: 3011-9.
131. Maiellaro-Rafferty K, Weiss D, Joseph G, Wan W, Gleason RL, Taylor WR. Catalase overexpression in aortic smooth muscle prevents pathological mechanical changes underlying abdominal aortic aneurysm formation. Am J Physiol Heart Circ Physiol 2011; 301: H355-62.
132. Basciano C, Kleinstreuer C, Hyun S, Finol EA. A relation between near-wall particle-hemodynamics and onset of thrombus formation in abdominal aortic aneurysms. Ann Biomed Eng 2011; 39: 2010- 26.
133. Biasetti J, Hussain F, Gasser TC. Blood flow and coherent vortices in the normal and aneurysmatic aortas: a fluid dynamical approach to intra-luminal thrombus formation. J R Soc Interface 2011; 8: 1449-61.
134. Touat Z, Ollivier V, Dai J, et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 2006; 168: 1022-30.
135. Ramos-Mozo P, Madrigal-Matute J, Vega de Ceniga M, et al. Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm. Atherosclerosis 2012; 220: 552-6.
136. Sagan A, Mrowiecki W, Mikolajczyk TP, et al. Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. Thromb Haemost 2012; 108: 812-23.
137. Wang DH, Makaroun MS, Webster MW, Vorp DA. Effect of intraluminal thrombus on wall stress in patient-specific models of abdominal aortic aneurysm. J Vasc Surg 2002; 36: 598-604.
138. Adolph R, Vorp DA, Steed DL, Webster MW, Kameneva MV, Watkins SC. Cellular content and permeability of intraluminal thrombus in abdominal aortic aneurysm. J Vasc Surg 1997; 25: 916-26.
139. Folkesson M, Silveira A, Eriksson P, Swedenborg J. Protease activity in the multi-layered intra-luminal thrombus of abdominal aortic aneurysms. Atherosclerosis 2011; 218: 294-9.
140. Delbosc S, Diallo D, Dejouvencel T, et al. Impaired high-density lipoprotein anti-oxidant capacity in human abdominal aortic aneurysm. Cardiovasc Res 2013; 100: 307-15.
141. Kazi M, Thyberg J, Religa P, et al. Influence of intraluminal thrombus on structural and cellular composition of abdominal aortic aneurysm wall. J Vasc Surg 2003; 38: 1283-92.
142. Watanabe J, Chou KJ, Liao JC, et al. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J Biol Chem 2007; 282: 23698-707.
143. Minneci PC, Deans KJ, Shiva S, et al. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol 2008; 295: H743-54.
144. Wu BJ, Chen K, Barter PJ, Rye KA. Niacin inhibits vascular inflammation via the induction of heme oxygenase-1. Circulation 2012; 125: 150-8.
145. Zaros PR, Pires CE, Bacci M, Jr., Moraes C, Zanesco A. Effect of 6-months of physical exercise on the nitrate/nitrite levels in hypertensive postmenopausal women. BMC Womens Health 2009; 9: 17.
146. Miyauchi T, Maeda S, Iemitsu M, et al. Exercise causes a tissuespecific change of NO production in the kidney and lung. J Appl Physiol (1985) 2003; 94: 60-8.
147. Kingwell BA. Nitric oxide as a metabolic regulator during exercise: effects of training in health and disease. Clin Exp Pharmacol Physiol 2000; 27: 239-50.
148. Langberg H, Bjorn C, Boushel R, Hellsten Y, Kjaer M. Exerciseinduced increase in interstitial bradykinin and adenosine concentrations in skeletal muscle and peritendinous tissue in humans. J Physiol 2002; 542: 977-83.
149. Ellsworth ML, Ellis CG, Goldman D, Stephenson AH, Dietrich HH, Sprague RS. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 2009; 24: 107-16.
150. Whyte JJ, Laughlin MH. The effects of acute and chronic exercise on the vasculature. Acta Physiol (Oxf) 2010; 199: 441-50.
151. Rehman J, Li J, Parvathaneni L, et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte- /macrophage-derived angiogenic cells. J Am Coll Cardiol 2004; 43: 2314-8.
152. Lindblad B, Borner G, Gottsater A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg 2005; 30: 346-52.
153. Myers J, Powell A, Smith K, Fonda H, Dalman RL, Stanford AAASI. Cardiopulmonary exercise testing in small abdominal aortic aneurysm: profile, safety, and mortality estimates. Eur J Cardiovasc Prev Rehabil 2011; 18: 459-66.
154. Kothmann E, Danjoux G, Owen SJ, Parry A, Turley AJ, Batterham AM. Reliability of the anaerobic threshold in cardiopulmonary exercise testing of patients with abdominal aortic aneurysms. Anaesthesia 2009; 64: 9-13.
155. Tew GA, Moss J, Crank H, Mitchell PA, Nawaz S. Endurance exercise training in patients with small abdominal aortic aneurysm: a randomized controlled pilot study. Arch Phys Med Rehabil 2012; 93: 2148-53.
156. Pouwels S, Willigendael EM, van Sambeek MR, Nienhuijs SW, Cuypers PW, Teijink JA. Beneficial Effects of Pre-operative Exercise Therapy in Patients with an Abdominal Aortic Aneurysm: A Systematic Review. Eur J Vasc Endovasc Surg 2014.
157. Grant SW, Hickey GL, Wisely NA, et al. Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repairdagger. Br J Anaesth 2015; 114: 430-6.
158. Kothmann E, Batterham AM, Owen SJ, et al. Effect of short-term exercise training on aerobic fitness in patients with abdominal aortic aneurysms: a pilot study. Br J Anaesth 2009; 103: 505-10.
159. Li MW, Mian MO, Barhoumi T, et al. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 2013; 33: 2306-15.
160. Flondell-Site D, Lindblad B, Gottsater A. High levels of endothelin (ET)-1 and aneurysm diameter independently predict growth of stable abdominal aortic aneurysms. Angiology 2010; 61: 324-8.
161. Tousoulis D, Oikonomou E, Siasos G, et al. Dose-dependent effects of short term atorvastatin treatment on arterial wall properties and on indices of left ventricular remodeling in ischemic heart failure. Atherosclerosis 2013; 227: 367-72.
162. Siasos G, Gouliopoulos N, Moschos MM, et al. Role of endothelial dysfunction and arterial stiffness in the development of diabetic retinopathy. Diabetes Care 2015; 38: e9-e10.
163. Tousoulis D, Androulakis E, Kontogeorgou A, et al. Insight to the pathophysiology of stable angina pectoris. Curr Pharm Des 2013; 19: 1593-600.
164. Huveneers S, Daemen MJ, Hordijk PL. Between Rho(k) and a Hard Place: The Relation Between Vessel Wall Stiffness, Endothelial Contractility, and Cardiovascular Disease. Circ Res 2015; 116: 895-908.
165. Jandu SK, Webb AK, Pak A, et al. Nitric oxide regulates tissue transglutaminase localization and function in the vasculature. Amino Acids 2013; 44: 261-9.
166. van den Akker J, VanBavel E, van Geel R, et al. The redox state of transglutaminase 2 controls arterial remodeling. PLoS One 2011; 6: e23067.
167. Upchurch GR, Jr., Ford JW, Weiss SJ, et al. Nitric oxide inhibition increases matrix metalloproteinase-9 expression by rat aortic smooth muscle cells in vitro. J Vasc Surg 2001; 34: 76-83.
168. Nar G, Soylu K, Akcay M, et al. Evaluation of the relationship between arterial blood pressure, aortic stiffness and serum endothelin- 1 levels in patients with essential hypertension. Clin Exp Hypertens 2013; 35: 589-94.
169. Ruegg G, Mason RH, Hardinge M, et al. Augmentation index and central aortic blood pressure in patients with abdominal aortic aneurysms. J Hypertens 2010; 28: 2252-7.
170. Durmus I, Kazaz Z, Altun G, Cansu A. Augmentation index and aortic pulse wave velocity in patients with abdominal aortic aneurysms. Int J Clin Exp Med 2014; 7: 421-5.
171. Lee CW, Sung SH, Chen CK, et al. Measures of carotid-femoral pulse wave velocity and augmentation index are not reliable in patients with abdominal aortic aneurysm. J Hypertens 2013; 31: 1853-60.
172. van Herwaarden JA, Muhs BE, Vincken KL, et al. Aortic compliance following EVAR and the influence of different endografts: determination using dynamic MRA. J Endovasc Ther 2006; 13: 406- 14.
173. Kadoglou NP, Moulakakis KG, Papadakis I, et al. Differential effects of stent-graft fabrics on arterial stiffness in patients undergoing endovascular aneurysm repair. J Endovasc Ther 2014; 21: 850-8.
174. Lantelme P, Dzudie A, Milon H, et al. Effect of abdominal aortic grafts on aortic stiffness and central hemodynamics. J Hypertens 2009; 27: 1268-76.
175. Moloney MA, McHugh S, DH OD, et al. Comparison of arterial stiffness and microcirculatory changes following abdominal aortic aneurysm grafting. Ir J Med Sci 2011; 180: 375-8.
176. Paraskevas KI, Bessias N, Psathas C, et al. Evaluation of aortic stiffness (aortic pulse-wave velocity) before and after elective abdominal aortic aneurysm repair procedures: a pilot study. Open Cardiovasc Med J 2009; 3: 173-5.
177. Shingu Y, Shiiya N, Ooka T, et al. Augmentation index is elevated in aortic aneurysm and dissection. Ann Thorac Surg 2009; 87: 1373-7.
178. Takeda Y, Sakata Y, Ohtani T, et al. Endovascular aortic repair increases vascular stiffness and alters cardiac structure and function. Circ J 2014; 78: 322-8.
179. Ashton JH, Vande Geest JP, Simon BR, Haskett DG. Compressive mechanical properties of the intraluminal thrombus in abdominal aortic aneurysms and fibrin-based thrombus mimics. J Biomech 2009; 42: 197-201.
180. Bosman WM, Hinnen JW, Kopp WH, et al. Influence of aneurysm wall stiffness and the presence of intraluminal thrombus on the wall movement of an aneurysm - an in vitro study. Vascular 2012; 20: 203-9.
181. Tong J, Cohnert T, Regitnig P, et al. Variations of dissection properties and mass fractions with thrombus age in human abdominal aortic aneurysms. J Biomech 2014; 47: 14-23.
182. Antoniades C, Demosthenous M, Tousoulis D, et al. Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension 2011; 58: 93-8.
183. Engstrom G, Borner G, Lindblad B, Janzon L, Lindgarde F. Incidence of fatal or repaired abdominal aortic aneurysm in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 2004; 24: 337-41.
184. Davis CA, 3rd, Pearce WH, Haines GK, Shah M, Koch AE. Increased ICAM-1 expression in aortic disease. J Vasc Surg 1993; 18: 875-80.
185. Fan J, Li X, Zhong L, et al. MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats. Folia Histochem Cytobiol 2010; 48: 455-61.
186. Wang Q, Ren J, Morgan S, Liu Z, Dou C, Liu B. Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm. PLoS One 2014; 9: e92053.
187. Hoh BL, Hosaka K, Downes DP, et al. Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1alpha and macrophage inflammatory protein-2-dependent pathway. Circulation 2011; 124: 2243-52.
188. Samadzadeh KM, Chun KC, Nguyen AT, Baker PM, Bains S, Lee ES. Monocyte activity is linked with abdominal aortic aneurysm diameter. J Surg Res 2014; 190: 328-34.
189. Appleton ND, Bailey DM, Morris-Stiff G, Lewis MH. Neutrophil to lymphocyte ratio predicts perioperative mortality following open elective repair of abdominal aortic aneurysms. Vasc Endovascular Surg 2014; 48: 311-6.
190. Takagi H, Watanabe T, Mizuno Y, Kawai N, Umemoto T, All- Literature Investigation of Cardiovascular Evidence G. Circulating Interleukin-6 Levels Are Associated with Abdominal Aortic Aneurysm Presence: A Meta-analysis and Meta-regression of Case- Control Studies. Ann Vasc Surg 2014; 28: 1913-22.
191. Vucevic D, Maravic-Stojkovic V, Vasilijic S, et al. Inverse production of IL-6 and IL-10 by abdominal aortic aneurysm explant tissues in culture. Cardiovasc Pathol 2012; 21: 482-9.
192. Oikonomou E, Siasos G, Tousoulis D. Pro-inflammatory interleukin genotypes potentiate early and advanced atherosclerosis differently. J Am Coll Cardiol 2014; 64: 848-9.
193. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, Baxter BT. Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 2001; 101: 152-6.
194. Elser B, Lohoff M, Kock S, et al. IFN-gamma represses IL-4 expression via IRF-1 and IRF-2. Immunity 2002; 17: 703-12.
195. Shimizu K, Shichiri M, Libby P, Lee RT, Mitchell RN. Th2- predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. J Clin Invest 2004; 114: 300-8.
196. Yates CM, Abdelhamid M, Adam DJ, Nash GB, Bradbury AW, Rainger GE. Endovascular aneurysm repair reverses the increased titer and the inflammatory activity of interleukin-1alpha in the serum of patients with abdominal aortic aneurysm. J Vasc Surg 2011; 54: 497-503.
197. Antoniades C, Bakogiannis C, Tousoulis D, Demosthenous M, Marinou K, Stefanadis C. Platelet activation in atherogenesis associated with low-grade inflammation. Inflamm Allergy Drug Targets 2010; 9: 334-45.
198. Papageorgiou N, Tousoulis D, Miliou A, et al. Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: focus on the coagulation cascade and endothelial function. Int J Cardiol 2013; 168: 4602-7.
199. Sbarouni E, Georgiadou P, Analitis A, Voudris V. Significant changes in platelet count, volume and size in acute aortic dissection. Int J Cardiol 2013; 168: 4349-50.
200. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011; 17: 47-58.
201. Davies RS, Abdelhamid M, Vohra RK, Bradbury AW, Adam DJ. The relationship between aortic aneurysm sac thrombus volume on coagulation, fibrinolysis and platelet activity. Thromb Res 2012; 130: 463-6.
202. Desbree A, Bonnard T, Blanchardon E, et al. Evaluation of Functionalized Polysaccharide Microparticles Dosimetry for SPECT Imaging Based on Biodistribution Data of Rats. Mol Imaging Biol 2014.
203. DiMusto PD, Lu G, Ghosh A, et al. Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol 2012; 302: H1378-86.
204. Dubis J, Zuk N, Grendziak R, Zapotoczny N, Pfanhauser M, Witkiewicz W. Activity of thrombin-activatable fibrinolysis inhibitor in the plasma of patients with abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2014; 25: 226-31.
205. Abdelhamid MF, Davies RS, Adam DJ, Vohra RK, Bradbury AW. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair. J Vasc Surg 2012; 55: 41-6.
206. Laufs U, Liao JK. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 1998; 273: 24266-71.
207. Kosmidou I, Moore JP, Weber M, Searles CD. Statin treatment and 3' polyadenylation of eNOS mRNA. Arterioscler Thromb Vasc Biol 2007; 27: 2642-9.
208. Aoki C, Nakano A, Tanaka S, et al. Fluvastatin upregulates endothelial nitric oxide synthase activity via enhancement of its phosphorylation and expression and via an increase in tetrahydrobiopterin in vascular endothelial cells. Int J Cardiol 2012; 156: 55-61.
209. Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ Res 2001; 89: 866-73.
210. Hattori Y, Nakanishi N, Akimoto K, Yoshida M, Kasai K. HMGCoA reductase inhibitor increases GTP cyclohydrolase I mRNA and tetrahydrobiopterin in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 176-82.
211. Wenzel P, Daiber A, Oelze M, et al. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis 2008; 198: 65-76.
212. de Sotomayor MA, Perez-Guerrero C, Herrrera MD, et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol 2005; 146: 1130- 8.
213. Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001; 37: 1450-7.
214. Wilson SH, Simari RD, Best PJ, et al. Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol 2001; 21: 122-8.
215. Piechota-Polanczyk A, Demyanets S, Mittlboeck M, et al. The Influence of Simvastatin on NGAL, Matrix Metalloproteinases and Their Tissue Inhibitors in Human Intraluminal Thrombus and Abdominal Aortic Aneurysm Tissue. Eur J Vasc Endovasc Surg 2015.
216. Evans J, Powell JT, Schwalbe E, Loftus IM, Thompson MM. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 2007; 34: 302-3.
217. Veillard NR, Braunersreuther V, Arnaud C, et al. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. Atherosclerosis 2006; 188: 51-8.
218. Lindholt JS, Heegaard NH, Vammen S, Fasting H, Henneberg EW, Heickendorff L. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2001; 21: 51- 6.
219. Takagi H, Yamamoto H, Iwata K, Goto S, Umemoto T, Group A. Effects of statin therapy on abdominal aortic aneurysm growth: a meta-analysis and meta-regression of observational comparative studies. Eur J Vasc Endovasc Surg 2012; 44: 287-92.
220. Golledge J, Cullen B, Moran C, Rush C. Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm. Cardiovasc Drugs Ther 2010; 24: 373-8.
221. Wang JA, Chen WA, Wang Y, et al. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms. Atherosclerosis 2011; 217: 90-6.
222. Galinanes EL, Reynolds S, Dombrovskiy VY, Vogel TR. The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes. Vascular 2014.
223. Krishna SM, Seto SW, Moxon JV, et al. Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. Am J Pathol 2012; 181: 706-18.
224. Wang JH, Eguchi K, Matsumoto S, et al. The omega-3 polyunsaturated fatty acid, eicosapentaenoic acid, attenuates abdominal aortic aneurysm development via suppression of tissue remodeling. PLoS One 2014; 9: e96286.
225. Wales KM, Kavazos K, Nataatmadja M, Brooks PR, Williams C, Russell FD. N-3 PUFAs protect against aortic inflammation and oxidative stress in angiotensin II-infused apolipoprotein E-/- mice. PLoS One 2014; 9: e112816.
226. Kavazos K, Nataatmadja M, Wales KM, Hartland E, Williams C, Russell FD. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Modulate Matrix Metalloproteinase Immunoreactivity in a Mouse Model of Pre-abdominal Aortic Aneurysm. Heart Lung Circ 2015; 24: 377-85.
227. Bhatta A, Yao L, Toque HA, et al. Angiotensin II-Induced Arterial Thickening, Fibrosis and Stiffening Involves Elevated Arginase Function. PLoS One 2015; 10: e0121727.
228. Kortekaas KE, Meijer CA, Hinnen JW, et al. ACE inhibitors potently reduce vascular inflammation, results of an open proof-ofconcept study in the abdominal aortic aneurysm. PLoS One 2014; 9: e111952.
229. Soehnlein O, Schmeisser A, Cicha I, et al. ACE inhibition lowers angiotensin-II-induced monocyte adhesion to HUVEC by reduction of p65 translocation and AT 1 expression. J Vasc Res 2005; 42: 399-407.
230. Ejiri J, Inoue N, Tsukube T, et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc Res 2003; 59: 988-96.
231. Andersson P, Bratt J, Heimburger M, Cederholm T, Palmblad J. Inhibition of neutrophil-dependent cytotoxicity for human endothelial cells by ACE inhibitors. Scand J Immunol 2014; 80: 339-45.
232. Takai S, Jin D, Yamamoto D, Li ZL, Otsuki Y, Miyazaki M. Significance of matrix metalloproteinase-9 inhibition by imidapril for prevention of abdominal aortic aneurysms in angiotensin II type 1 receptor-knockout mice. J Pharmacol Sci 2013; 123: 185-94.
233. Karlsson L, Gnarpe J, Bergqvist D, Lindback J, Parsson H. The effect of azithromycin and Chlamydophilia pneumonia infection on expansion of small abdominal aortic aneurysms--a prospective randomized double-blind trial. J Vasc Surg 2009; 50: 23-9.
234. Hogh A, Vammen S, Ostergaard L, Joensen JB, Henneberg EW, Lindholt JS. Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial. Vasc Endovascular Surg 2009; 43: 452-6.
235. Siasos G, Tousoulis D, Kokkou E, et al. Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens 2014; 27: 38-45.
236. Lindqvist M, Hellstrom A, Henriksson AE. Abdominal aortic aneurysm and the association with serum levels of Homocysteine, vitamins B6, B12 and Folate. Am J Cardiovasc Dis 2012; 2: 318-22.
237. Shang T, Liu Z, Liu CJ. Antioxidant Vitamin C attenuates experimental abdominal aortic aneurysm development in an elastaseinduced rat model. J Surg Res 2014; 188: 316-25.
238. Tanaka A, Hasegawa T, Morimoto K, et al. Controlled release of ascorbic acid from gelatin hydrogel attenuates abdominal aortic aneurysm formation in rat experimental abdominal aortic aneurysm model. J Vasc Surg 2014; 60: 749-58.
239. Gavrila D, Li WG, McCormick ML, et al. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2005; 25: 1671-7.
240. Siasos G, Tousoulis D, Oikonomou E, et al. Vitamin D3, D2 and arterial wall properties in coronary artery disease. Curr Pharm Des 2014; 20: 5914-8.
241. Wong YY, Flicker L, Yeap BB, McCaul KA, Hankey GJ, Norman PE. Is hypovitaminosis D associated with abdominal aortic aneurysm, and is there a dose-response relationship? Eur J Vasc Endovasc Surg 2013; 45: 657-64.
242. Wang L, Wang B, Li H, et al. Quercetin, a flavonoid with antiinflammatory activity, suppresses the development of abdominal aortic aneurysms in mice. Eur J Pharmacol 2012; 690: 133-41.
243. Wang L, Cheng X, Li H, et al. Quercetin reduces oxidative stress and inhibits activation of cJun Nterminal kinase/activator protein1 signaling in an experimental mouse model of abdominal aortic aneurysm. Mol Med Rep 2014; 9: 435-42.
244. Robertson L, Atallah E, Stansby G. Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm. Cochrane Database Syst Rev 2014; 1: CD010447.
245. Papageorgiou N, Tousoulis D, Katsargyris A, et al. Antioxidant treatment and endothelial dysfunction: is it time for flavonoids? Recent Pat Cardiovasc Drug Discov 2013; 8: 81-92.
246. Fujiwara Y, Shiraya S, Miyake T, et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int J Mol Med 2008; 22: 703-8.